These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1408523)

  • 21. Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
    Tanhehco JL; Wiechers DO; Golbus J; Neely SE
    Muscle Nerve; 1992 May; 15(5):561-7. PubMed ID: 1584247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic rheumatic disorders.
    Clauw DJ; Crofford LJ
    Rheum Dis Clin North Am; 1995 Feb; 21(1):231-46. PubMed ID: 7732171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents.
    Priori R; Conti F; Luan FL; Arpino C; Valesini G
    Eur J Pediatr; 1994 May; 153(5):344-6. PubMed ID: 8033924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
    Mensing H; Schallreuter KU; Senff H; Steinkraus V
    Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eosinophilic myalgia syndrome].
    Vermel' AE
    Klin Med (Mosk); 1999; 77(2):4-7. PubMed ID: 10380452
    [No Abstract]   [Full Text] [Related]  

  • 27. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
    Clauw DJ; Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
    [No Abstract]   [Full Text] [Related]  

  • 28. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome.
    Johnson KL; Klarskov K; Benson LM; Williamson BL; Gleich GJ; Naylor S
    J Rheumatol; 1999 Dec; 26(12):2714-7. PubMed ID: 10606395
    [No Abstract]   [Full Text] [Related]  

  • 29. [Muscle pain, scleroderma-like skin changes and eosinophilia following administration of a psychotropic drug].
    Scheurlen C; Neubrand M; Fischer G; Soehnchen R; Kröner G; Sauerbruch T
    Internist (Berl); 1992 Apr; 33(4):269-73. PubMed ID: 1612852
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilia-myalgia syndrome and peripheral eosinophilia.
    Schwartzberg M; Weber CA
    J Rheumatol; 1991 Dec; 18(12):1940-1. PubMed ID: 1795341
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
    Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
    J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of L-tryptophan and eosinophilia-myalgia syndrome.
    Roufs JB
    J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myalgia-eosinophilia syndrome. Tryptophan disease].
    Cabane J
    Rev Prat; 1991 Dec; 41(25):2583-7. PubMed ID: 1803472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Eosinophilia-myalgia syndrome].
    Heuschling C
    Bull Soc Sci Med Grand Duche Luxemb; 1992; 129(2):17-23. PubMed ID: 1340406
    [No Abstract]   [Full Text] [Related]  

  • 36. The eosinophilia-myalgia syndrome revisited.
    Belongia EA; Gleich GJ
    J Rheumatol; 1996 Oct; 23(10):1682-5. PubMed ID: 8895139
    [No Abstract]   [Full Text] [Related]  

  • 37. [A lesson on the purity of pharmaceutical products derived from biotechnology: eosinophilia-myalgia syndrome].
    Boll Chim Farm; 1995; 134(7):394-5. PubMed ID: 7546544
    [No Abstract]   [Full Text] [Related]  

  • 38. Head and neck manifestations of eosinophilia-myalgia syndrome.
    Levine B; Lanza DC; Ficco A; Freundlich B
    Ann Otol Rhinol Laryngol; 1995 Feb; 104(2):90-9. PubMed ID: 7857025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
    Sullivan EA; Staehling N; Philen RM
    J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.